Terence A. Riauka

Edmonton, AB, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Edmonton, AB, CA 

Overview

Terence Riauka practices practicing medicine in Edmonton, Canada.

His clinical expertise encompasses Pancreatic Islet Cell Tumor and Neuroendocrine Tumor.

He is actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Edmonton, AB, Canada
Other Locations
Edmonton, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase I/II Study of Gallium-68 HA-DOTATATE ([68]Ga-HA-DOTATATE) in Patients With Known or Suspected Somatostatin Receptor Positive Tumours
A Phase I/II Study of Gallium-68 HA-DOTATATE ([68]Ga-HA-DOTATATE) in Patients With Known or Suspected Somatostatin Receptor Positive Tumours
Enrollment Status: Recruiting
Publish Date: May 14, 2025
Intervention Type: Drug
Study Drug: [68]Ga-HA-DOTATATE
Study Phase: Phase 1/Phase 2
A Pivotal Phase III Study of Cyclotron-produced Tc-99m Pertechnetate (CTC) Compared to Generator-produced Tc-99m Pertechnetate (G-PERT) in Subjects With Thyroid Disorders
A Pivotal Phase III Study of Cyclotron-produced Tc-99m Pertechnetate (CTC) Compared to Generator-produced Tc-99m Pertechnetate (G-PERT) in Subjects With Thyroid Disorders
Enrollment Status: Completed
Publish Date: April 11, 2022
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

15 Total Publications

Safeguarding Global AI Progress: The Role of Scientific Societies in Ensuring Equitable Data Access in Nuclear Medicine.
Safeguarding Global AI Progress: The Role of Scientific Societies in Ensuring Equitable Data Access in Nuclear Medicine.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 15, 2025

Frequently Asked Questions about Terence A. Riauka

Is Terence A. Riauka a top-rated expert for Pancreatic Islet Cell Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Terence A. Riauka is classified as an Experienced expert for Pancreatic Islet Cell Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Terence A. Riauka participate in research or clinical trials?

Yes. Terence A. Riauka has published 15 articles and abstracts on conditions like Pancreatic Islet Cell Tumor. You can view a list of Terence A. Riauka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Riauka's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile